NEWTON, MA--(Marketwired - Jul 11, 2013) - Kaminario, the leading scale-out all-flash array provider, today announced that Conatus Capital Management LP ("Conatus"), a Connecticut-based investment ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

(Reuters) - Conatus Pharmaceuticals Inc said on Monday it plans to explore options and implement a restructuring plan after its liver disease drug failed in a mid-stage trial. The drug developer's ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) saw its ...

San Diego biotech Histogen went public Wednesday through a merger with fellow local biotech Conatus Pharmaceuticals. The combined company will operate under Histogen’s name and mission: replacing and ...

SAN DIEGO, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) and Histogen Inc., a privately-held regenerative medicine company with a novel biological platform that ...

Jan 8 (Reuters) - Conatus Pharmaceuticals Inc said on Thursday initial results from small early stage trials supported continued development of its experimental drug for patients with cirrhosis and ...

Conatus' lead powerful compound, emricasan, is a first-in-class, orally active caspase protease inhibitor. Caspases are a family of related enzymes that play an important role as modulators of ...

Proposed Merger Creates Regenerative Medicine Company with Three Clinical-stage Product Candidates and Combined Company Capitalization Expected to Support Operations into 2021 Companies to Hold a ...

Shares of Conatus Pharmaceuticals Inc. CNAT have declined sharply in the past three months. In fact, the stock has plunged 60.6%, wider than the industry’s dip of 2.8%. In March 2019, Conatus ...